Cases & Deals

  • Home
  • Practices
  • ToolGen defends revolutionary CRISPR technology patent

Share

ToolGen defends revolutionary CRISPR technology patent

August 2019

Client(s) ToolGen, Inc.

Jones Day is acting for ToolGen, Inc. in relation to a challenge to its patent rights concerning CRISPR, a technology that has revolutionized the field of molecular biology including gene editing in the medical, biotechnology, and agricultural and farming industries.

Grant Fisher v. ToolGen Incorporated [2018] APO 65

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.